Testing effectiveness (Phase 2)Study completedNCT02733432
What this trial is testing
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
Who this might be right for
Candidiasis, VulvovaginalMycosesYeast Infection+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 126